Home > Insider Trading > Filing (0000899243-19-010617)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1217234	Caredx Inc.	CDNA	Services-Medical Laboratories (8071)	943316839

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1721150	Sasha King	C/O Caredx, Inc. 3260 Bayshore Boulevard Brisbane CA 94005	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-04-12	1,250	$1.00	75,137	No	4	M	Direct
Common Stock	Acquisiton	2019-04-12	1,041	$1.07	76,178	No	4	M	Direct
Common Stock	Acquisiton	2019-04-12	416	$2.80	76,594	No	4	M	Direct
Common Stock	Acquisiton	2019-04-12	4,167	$5.90	80,761	No	4	M	Direct
Common Stock	Acquisiton	2019-04-12	5,833	$6.31	86,594	No	4	M	Direct
Common Stock	Disposition	2019-04-12	10,000	$29.81	76,594	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2019-04-12	1,250	$0.00	1,250	$1.00
Common Stock	Employee Stock Option (right to buy)	Disposition	2019-04-12	1,041	$0.00	1,041	$1.07
Common Stock	Employee Stock Option (right to buy)	Disposition	2019-04-12	416	$0.00	416	$2.80
Common Stock	Employee Stock Option (right to buy)	Disposition	2019-04-12	4,167	$0.00	4,167	$5.90
Common Stock	Employee Stock Option (right to buy)	Disposition	2019-04-12	5,833	$0.00	5,833	$6.31

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,000	2027-04-21	No	4	M	Direct
5,417	2027-06-09	No	4	M	Direct
4,028	2027-09-01	No	4	M	Direct
25,833	2027-10-27	No	4	M	Direct
14,167	2028-01-19	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $31.43, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
25% of the shares subject to the option vested on March 30, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
25% of the shares subject to the option vested on June 9, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
50% of the shares subject to the option vested on September 1, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.